U.S., Nov. 5 -- ClinicalTrials.gov registry received information related to the study (NCT07917377) titled 'Magnetoencephalographic Correlates of Clinical Change After Cognitive Processing Therapy in ... Read More
U.S., Nov. 5 -- ClinicalTrials.gov registry received information related to the study (NCT07917702) titled 'Effects of Transcranial Direct Current Stimulation and Manual Therapy on Musculoskeletal Pai... Read More
U.S., Nov. 5 -- ClinicalTrials.gov registry received information related to the study (NCT07915401) titled 'Bacterial Reduction in Apical Root Canals After Bioceramic or Calcium Hydroxide Medicament' ... Read More
U.S., Nov. 5 -- ClinicalTrials.gov registry received information related to the study (NCT07915830) titled 'Comparing Two Laparoscopic Techniques for Hernia Repair in Children' on Oct. 29. Brief Summ... Read More
U.S., Nov. 5 -- ClinicalTrials.gov registry received information related to the study (NCT07915024) titled 'Phase 1 Study to Assess the Effects of HSK31858 on the QT/QTc Interval in Healthy Chinese Pa... Read More
U.S., Nov. 5 -- ClinicalTrials.gov registry received information related to the study (NCT07917221) titled 'Proof-of-concept for Use of Transcutaneous Spinal Stimulation (TSS) With the ExaStim(R) Stim... Read More
U.S., Nov. 5 -- ClinicalTrials.gov registry received information related to the study (NCT07915778) titled 'Compression-Only Versus Standard Basic Life Support Training in Nursing Students' on Oct. 21... Read More
Mumbai, Nov. 5 -- Zerodha Mutual Fund has announced change in scheme names under the following schemes, with effect from 02 November 2026. Table, th, td {border: 1px Solid black; Border-collapse: co... Read More
Singapore, Nov. 5 -- The Health Sciences Authority received information related to the study titled 'FRAmework-01: A Three-Part Phase 3 Study of Sofetabart Mipitecan (LY4170156) versus Chemotherapy or... Read More
Singapore, Nov. 5 -- The Health Sciences Authority received information related to the study titled 'A Randomized, Open-Label, Phase 3 Study of Rinatabart Sesutecan (Rina-S) Plus Standard of Care Vers... Read More